A material will not have to be outlined to be a controlled substance through the DEA being handled being a Plan I substance for prison prosecution. A managed compound analogue (as an example, a "designer drug") is really a material and that is structurally or pharmacologically much like a Plan I or Routine II compound, particularly useful for human